Cargando…

776. Effect of the SEP-1 Sepsis Bundle on Mortality in Hospital-Onset v. Community-Onset Sepsis

BACKGROUND: The SEP-1 sepsis bundle is a performance measure from the Centers for Medicare and Medicaid Services that requires blood cultures, serum lactate, broad-spectrum antibiotics, and IV fluids (in some cases) within 3 hours of onset of sepsis. Published evidence regarding an effect of SEP-1 o...

Descripción completa

Detalles Bibliográficos
Autores principales: Baghdadi, Jonathan, Uslan, Daniel, Bell, Douglas, Wong, Mitchell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811200/
http://dx.doi.org/10.1093/ofid/ofz360.844
_version_ 1783462423460577280
author Baghdadi, Jonathan
Uslan, Daniel
Bell, Douglas
Wong, Mitchell
author_facet Baghdadi, Jonathan
Uslan, Daniel
Bell, Douglas
Wong, Mitchell
author_sort Baghdadi, Jonathan
collection PubMed
description BACKGROUND: The SEP-1 sepsis bundle is a performance measure from the Centers for Medicare and Medicaid Services that requires blood cultures, serum lactate, broad-spectrum antibiotics, and IV fluids (in some cases) within 3 hours of onset of sepsis. Published evidence regarding an effect of SEP-1 on mortality is mixed and largely excludes cases of hospital-onset sepsis. METHODS: Retrospective cohort study using clinical data from 4 University of California hospitals. Sepsis-related admissions from 2014–2017 were identified by diagnosis codes. We compared the effect of the SEP-1 sepsis bundle on in-hospital mortality in cohorts with community-onset and hospital-onset sepsis. To control for selection bias, patients who did and did not receive the SEP-1 bundle from each cohort were balanced on key variables related to likelihood of treatment using Mahalanobis distance matching. RESULTS: 5,034 out of 6,005 sepsis-related patient encounters were matched, including 1,770 (35%) patients who received the SEP-1 bundle and 3,264 (65%) who did not. The SEP-1 bundle was not associated with an effect on mortality in the unmatched (Table 2) or matched analyses (Table 3). Point estimates from the matched analysis suggested a greater potential benefit associated with SEP-1 and its components in community-onset sepsis, but differences in effect size between community-onset and hospital-onset were nonsignificant. Among bundle components, timely blood cultures, lactate, and antibiotics were not associated with an effect on mortality, while IV fluids were associated with a 3-percentage-point increase in mortality risk. In subgroup analysis, IV fluids were associated with increased mortality in patients with pneumonia and immunosuppression. CONCLUSION: The use of the SEP-1 sepsis bundle was not associated with an effect on mortality. Subgroup analyses suggested situations in which IV fluids may be harmful, though prospective data are needed. [Image: see text] [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6811200
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68112002019-10-29 776. Effect of the SEP-1 Sepsis Bundle on Mortality in Hospital-Onset v. Community-Onset Sepsis Baghdadi, Jonathan Uslan, Daniel Bell, Douglas Wong, Mitchell Open Forum Infect Dis Abstracts BACKGROUND: The SEP-1 sepsis bundle is a performance measure from the Centers for Medicare and Medicaid Services that requires blood cultures, serum lactate, broad-spectrum antibiotics, and IV fluids (in some cases) within 3 hours of onset of sepsis. Published evidence regarding an effect of SEP-1 on mortality is mixed and largely excludes cases of hospital-onset sepsis. METHODS: Retrospective cohort study using clinical data from 4 University of California hospitals. Sepsis-related admissions from 2014–2017 were identified by diagnosis codes. We compared the effect of the SEP-1 sepsis bundle on in-hospital mortality in cohorts with community-onset and hospital-onset sepsis. To control for selection bias, patients who did and did not receive the SEP-1 bundle from each cohort were balanced on key variables related to likelihood of treatment using Mahalanobis distance matching. RESULTS: 5,034 out of 6,005 sepsis-related patient encounters were matched, including 1,770 (35%) patients who received the SEP-1 bundle and 3,264 (65%) who did not. The SEP-1 bundle was not associated with an effect on mortality in the unmatched (Table 2) or matched analyses (Table 3). Point estimates from the matched analysis suggested a greater potential benefit associated with SEP-1 and its components in community-onset sepsis, but differences in effect size between community-onset and hospital-onset were nonsignificant. Among bundle components, timely blood cultures, lactate, and antibiotics were not associated with an effect on mortality, while IV fluids were associated with a 3-percentage-point increase in mortality risk. In subgroup analysis, IV fluids were associated with increased mortality in patients with pneumonia and immunosuppression. CONCLUSION: The use of the SEP-1 sepsis bundle was not associated with an effect on mortality. Subgroup analyses suggested situations in which IV fluids may be harmful, though prospective data are needed. [Image: see text] [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6811200/ http://dx.doi.org/10.1093/ofid/ofz360.844 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Baghdadi, Jonathan
Uslan, Daniel
Bell, Douglas
Wong, Mitchell
776. Effect of the SEP-1 Sepsis Bundle on Mortality in Hospital-Onset v. Community-Onset Sepsis
title 776. Effect of the SEP-1 Sepsis Bundle on Mortality in Hospital-Onset v. Community-Onset Sepsis
title_full 776. Effect of the SEP-1 Sepsis Bundle on Mortality in Hospital-Onset v. Community-Onset Sepsis
title_fullStr 776. Effect of the SEP-1 Sepsis Bundle on Mortality in Hospital-Onset v. Community-Onset Sepsis
title_full_unstemmed 776. Effect of the SEP-1 Sepsis Bundle on Mortality in Hospital-Onset v. Community-Onset Sepsis
title_short 776. Effect of the SEP-1 Sepsis Bundle on Mortality in Hospital-Onset v. Community-Onset Sepsis
title_sort 776. effect of the sep-1 sepsis bundle on mortality in hospital-onset v. community-onset sepsis
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811200/
http://dx.doi.org/10.1093/ofid/ofz360.844
work_keys_str_mv AT baghdadijonathan 776effectofthesep1sepsisbundleonmortalityinhospitalonsetvcommunityonsetsepsis
AT uslandaniel 776effectofthesep1sepsisbundleonmortalityinhospitalonsetvcommunityonsetsepsis
AT belldouglas 776effectofthesep1sepsisbundleonmortalityinhospitalonsetvcommunityonsetsepsis
AT wongmitchell 776effectofthesep1sepsisbundleonmortalityinhospitalonsetvcommunityonsetsepsis